Posthypoxic myoclonus (Lance-Adams Syndrome) treated with lacosamide

Clinical Neuropharmacology

Volumn 33, Issue 4, 2010, Pages 216-217

  Galldiks, Norbert ^a   Timmermann, Lars ^a   Fink, Gereon Rudolf ^a   Burghaus, Lothar ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; ETIRACETAM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; PIRACETAM; PROPOFOL; THIOPENTAL; VALPROIC ACID;

ADAMS LANCE SYNDROME; ARTIFICIAL VENTILATION; DISEASE EXACERBATION; HEART ARREST; HEART INFARCTION; LETTER; LOW DRUG DOSE; MYOCLONUS; PATIENT CARE; POSTHYPOXIC MYOCLONUS; PRIORITY JOURNAL; RARE DISEASE; TENDON REFLEX; VOLUNTARY MOVEMENT;

ACETAMIDES; AGED; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; HUMANS; HYPOXIA, BRAIN; MALE; MYOCARDIAL INFARCTION; MYOCLONUS;

EID: 77955150316     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181e1613f     Document Type: Letter

References (6)

1. Frucht S, Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000;15:2-7.
2. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol 2004;3:598-607.
3. Frucht SJ, Louis ED, Chuang C, et al. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology 2001;57: 1112-1114.
4. Muslu B, Kilci O, Horasanli E, et al. Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation. Clin Neuropharmacol 2009;32:236.
5. Arpesella R, Dallocchio C, Arbasino C, et al. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesth Intensive Care 2009;37: 314-318.
6. Beydoun A, D'Souza J, Hebert D, et al. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother 2009; 9:33-42.